haloperidol decanoat-richter 50mg/ml injekční roztok
gedeon richter plc., budapešť array - 9957 haloperidol-dekanoÁt - injekční roztok - 50mg/ml - haloperidol
haloperidol-richter 1,5mg tableta
gedeon richter plc., budapešť array - 689 haloperidol - tableta - 1,5mg - haloperidol
haloperidol-richter 2mg/ml perorální kapky, roztok
gedeon richter plc., budapešť array - 689 haloperidol - perorální kapky, roztok - 2mg/ml - haloperidol
haloperidol-richter 5mg/ml injekční roztok
gedeon richter plc., budapešť array - 689 haloperidol - injekční roztok - 5mg/ml - haloperidol
flonidan 10mg tableta
lek pharmaceuticals d.d., ljubljana array - 10425 loratadin - tableta - 10mg - loratadin
amisulprid viatris 200mg tableta
mylan ireland limited, dublin array - 8840 amisulprid - tableta - 200mg - amisulprid
amisulprid viatris 50mg tableta
mylan ireland limited, dublin array - 8840 amisulprid - tableta - 50mg - amisulprid
mibg(i123) 74mbq/ml injekční roztok
curium netherlands b.v., petten array - 13550 jobenguan-(123i); 13551 jobenguan-sulfÁt - injekční roztok - 74mbq/ml - jobenguan-(123i)
suxamethonium chlorid vuab 100mg prášek pro injekční/infuzní roztok
vuab pharma a.s., roztoky array - 12412 dihydrÁt suxamethonium-chloridu - prášek pro injekční/infuzní roztok - 100mg - suxamethonium
sarclisa
sanofi winthrop industrie - isatuximab - mnohočetný myelom - antineoplastická činidla - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.